Want to Try Psychedelics in a Clinical Setting? 116 Trials Now Recruiting Volunteers (UPDATED)
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, DMT and 5-MeO-DMT studies.
Virgina Haze, the co-author of “The Psilocybin Chef Cookbook,” promises a psychedelic experience “can be delicious as well as trippy.”
Delic establishes medical board to oversee psychedelic treatment protocols, cool new delivery systems investigated for psychedelics, and VR meets psychedelic therapies, finally.
Since May 2019, nine cities and the state of Oregon have decriminalized psychedelics. Carlos Plazola has had his hand in nearly all of them.
This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing.
This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain, and eating disorders.
The clinics provide high-dose ketamine infusions, as well as intramuscular ketamine infusions for group therapy.
Another clinic gets approval to conduct MDMA research, and new psychedelic research facilities open in Australia and the U.S., plus two game-changing psilocybin patents.
“Our app was designed with accessibility and ease of use as top priorities, so that psychedelic users in any state of mind can connect quickly with our diverse and compassionate peer support line volunteers,” says the nonprofit’s co-founder.
City Commissioner Kurt Reppart believes there is enough support to pass a resolution as early as fall.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.